Mateon Therapeutics Inc. buy agenda2020
Start price
15.05.15
/
50%
€1.21
Target price
09.06.15
€2.50
Performance (%)
9.38%
End price
09.06.15
€1.32
Summary
This prediction ended on 09.06.15 with a price of €1.32. With a performance of 9.38%, the BUY prediction by agenda2020 for Mateon Therapeutics Inc. closed with a slight gain. agenda2020 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mateon Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -3,51 % | -8,75 % | -1,00 % | 48,50 % |
| iShares Nasdaq 100 | -2,78 % | -0,63 % | 14,22 % | 78,81 % |
| iShares Nikkei 225® | -2,04 % | -6,84 % | 24,87 % | 51,56 % |
| iShares S&P 500 | -2,60 % | -2,23 % | 9,20 % | 60,51 % |
Comments by agenda2020 for this prediction
In the thread Mateon Therapeutics Inc. diskutieren
tumor ohne o2
phase 2/3 studien bei ovarialca. phase 1 bei leukämie.
drücken wir die daumen!!!
(Vom Mitglied beendet)


